The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...

US equity markets rallied into the close on Wednesday with the Dow hitting a fresh record high as more forecast-beating ...

Novavax Inc. shares fell as much as 24% after US regulators placed a hold on the company’s experimental influenza and ...

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, ...

The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...

A few of my picks for the best penny stocks on Robinhood include Serve Robotics and BranchOut Food. See why you might want to ...

The Dow Jones Industrial Average was higher at midday Wednesday as strong earnings reports offset continued worries about the ...

Novavax Inc. shares fell 19% after US regulators placed a hold on the company’s experimental vaccines because a study ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.